Immune-mediated neuropathy with epstein-barr virus-positive T-cell lymphoproliferative disease

1Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

A 47-year-old man with Epstein-Barr virus (EBV)-positive T/NK- cell lymphoproliferative disease (EBVT/ NK-LPD) developed acute-onset weakness. A nerve conduction study showed a conduction block in both the proximal and most distal segments. Although the patient’s neuropathy transiently responded to intravenous immunoglobulin, it was progressive for at least 25 days until the start of prednisolone (PSL) administration, after which it remarkably improved. The neuropathy further improved after allogeneic bone marrow transplantation (BMT). The present patient’s clinical course is not consistent with that of typical Guillain- Barre syndrome. This case suggests that EBV-T/NK-LPD can cause progressive immune-mediated neuropathy as a result of chronic EBV antigen presentation and can be treated with PSL and BMT.

Cite

CITATION STYLE

APA

Hattori, T., Arai, A., Yokota, T., Imadome, K. I., Tomimitsu, H., Miura, O., & Mizusawa, H. (2015). Immune-mediated neuropathy with epstein-barr virus-positive T-cell lymphoproliferative disease. Internal Medicine, 54(1), 69–73. https://doi.org/10.2169/internalmedicine.54.3173

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free